Pediatric drug development in China: Reforms and challenges
Author:
Funder
National Natural Science Foundation of China
Shanghai Municipal Health Commission
Publisher
Elsevier BV
Subject
Pharmacology
Reference45 articles.
1. Off-label drug use in pediatric patients;Kimland;Clin. Pharmacol. Ther.,2012
2. Pediatric information in drug product labeling;Sachs;JAMA,2012
3. The march toward rational therapeutics in children;Gorman;Pediatr. Infect. Dis. J.,2003
4. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies;Roberts;JAMA,2003
5. Paediatric pharmacokinetics: key considerations;Batchelor;Br. J. Clin. Pharmacol.,2015
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Paediatric off-label use of drugs in Gansu, China: a multicentre cross-sectional study;BMJ Open;2024-05
2. Recent landscape and trends for industry‐sponsored pediatric clinical trials in China from 2013 to 2022;Pediatric Investigation;2024-01-03
3. The needs, challenges, and opportunities from the academic researchers' perspective;Essentials of Translational Pediatric Drug Development;2024
4. Pediatric Drug Development: Reviewing Challenges and Opportunities by Tracking Innovative Therapies;Pharmaceutics;2023-10-06
5. Local Government Debt and Its Impact on Corporate Underinvestment and ESG Performance: Empirical Evidence from China;Sustainability;2023-07-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3